Aug 25, 2010 – Antigenics, Inc. herpes zoster vaccine candidate, which contains Antigenics' QS- 21 Stimulon® adjuvant as a key.

Business editors health care conference agreement license agreements , antigenics nasdaqagen oncophage Nasdaq agen on like to lexington biotechsep .

Oct 25, 2010 – Antigenics could easily have thrown in the towel on its immune boosting therapy for cancer. But now the Lexington, MA-based biotech company, .

Jul 28, 2010 – Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2, .

US:AGEN - Get Stock quote detail for Antigenics Inc. Stock quotes include the latest US:AGEN market price and fundamental investing data, price charts and.

Jul 22, 2009 – Antigenics Inc., a biotechnology company, engages in developing and commercializing technologies to treat cancers and infectious diseases, .

Antigenics to host conference call. Theflyonthewall.com . Cancer and other diseases had better beware -- Agenus (formerly Antigenics) is packing heat. .

Antigenics news by StockNod. Get the latest AGEN stock news from Antigenics blogs, press releases, pod casts, and earnings call company information for .

Antigenics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis (June 24, 2011) | Market Research Reports .

Welcome to the company profile of Antigenics on LinkedIn. Antigenics, Inc., a biotechnology company, develops treatments for cancers and infectious diseases .

Oct 25, 2009 – News that a European advisory committee won't recommend approval of Antigenics' kidney cancer vaccine Oncophage (vitespen) provides yet a.

Pharmaceutical company profile for Antigenics Inc.

Jan 6, 2011 – Says name change effective immediately * Implements name changes for some compounds Jan 6 (Reuters) - Antigenics Inc said it ischanging its .

Jun 17, 2011 – Antigenics Inc. is a biotechnology company developing technologies and products to treat cancers, infectious diseases and autoimmune .

Sep 29, 2009 – Antigenics, Inc., a biotechnology company, develops treatments for cancers and infectious diseases. It offers Oncophage, a personalized .

File Format: PDF/Adobe Acrobat - Quick View

Apr 12, 2010 – Antigenics (Nasdaq:AGEN) Oncophage, not Denderon's Provenge, is the First Cancer Vaccine to Gain Approval Active cancer immunotherapy .

Antigenics initiates Phase I clinical trial of AG-707 therapeutic vaccine for genital herpes from Journal of Drugs in Dermatology provided by Find Articles .

Apr 13, 2010 – One currently overlooked company which is in fact much farther along than all the above mentioned companies is Antigenics (AGEN). .

SPEC designed and built Antigenics' 30000 sqft pilot scale manufacturing facility & met the expedited schedule by pre-ordering major capital equipment .

May 7, 2001 – The Deal: Antigenics Inc. has agreed to purchase Aronex Pharmaceuticals Inc. for $28.5 million in stock. The acquisition will give .

Jun 22, 2011 – He founded Antigenics 15 years ago. He's been building his company around . . Maybe Garo's Antigenics is on to something really important. .

Research about Antigenics Inc., including news, information, and reports with HighBeam Business : Arrive Prepared.

Antigenics (AGEN) is a biotechnology company focusing on the development of cancer vaccines and autoimmune disorders. Its main product, a renal.

Apr 9, 2008 – Tuesday morning, a little biotech company, Antigenics (AGEN), announced that Russia has approved its kidney cancer drug, Oncophage. .

Apr 28, 2011. Q1 2011 Antigenics Earnings Release . Agenus Inc., formerly Antigenics Inc., develops and commercializes immunotherapies for cancer and .

. ValuEngine Industry Report for Medical-biomed/genetics ValuEngine, Inc .

Antigenics Inc. financial and business news, updates, and information from The New York Times and other leading providers.

Antigenics Leah is the Director of Quality Assurance of Antigenics. Details from Lead411 could include email - @antigenics.com, phone, and biography. by .

How does Antigenics Incorporated's balance sheet structure differs from global benchmarks? Does Antigenics Incorporated hold more cash and short-term assets .

Antigenics (AGEN) stock quote, charts, data, historical data, financials. Antigenics Inc. is a biotechnology company founded in 1994 by Garo H. Armen and .

Antigenics is developing a therapeutic cancer vaccine based on heat-shock proteins (HSPs). The vaccine [HSPPC-96, Oncophage] is in a pivotal phase III .

Aug 26, 2010 – FierceBiotech | Compare Top Solutions in: FEATURES >> GlaxoSmithKline isn't the only company cheering the launch of a late-stage program for .

Jun 30, 2011 – As of January 6, 2011, we changed our name from Antigenics Inc. to Agenus Inc. to more accurately reflect our existing product pipeline, .

News on Antigenics (Ticker: AGEN) continually updated from thousands of sources around the net.

Research Antigenics with InvestorGuide.com stock research tool. AGEN company news, press releases, articles, earnings targets, SEC filings, and insider .

On or about February 3, 2000, Antigenics commenced an initial public offering of . In connection therewith, Antigenics filed a registration statement, .

Antigenics, Inc. - Financial and Strategic Analysis Review, Antigenics, Inc. - Financial and Strategic Analysis ReviewSummaryAntigenics Inc. (Antigenics) is .

Get directions, reviews, payment information on Antigenics Inc located at New York, NY. Search for other Hospitals in New York.

Antigenics stock Price (AGEN), Stock Quotes and FREE real time streaming Antigenics Stock Charts, company fundamentals, Level 2 Data, Discussion Forums as .

Mar 11, 2010 – Antigenics Inc. (AGEN) Chairman & CEO Garo H Armen sells 87628 Shares, Stocks: AGEN, release date:Mar. 11, 2010.

Apr 21, 2010 – A new brain tumor vaccine designed to use a patient's own cells is now in mid- stage trials and could offer new hope to patients who have .

Mar 3, 2007 – Company Profile for Antigenics's Company Profile, News and Jobs - Antigenics is a biotechnology company that is involved in the development .

Jun 1, 2009 – Drug stocks gain ground as shares of Elan Corp. soar on speculation that the company could be taken over by Bristol-Myers Squibb.

Feb 17, 2011 – Antigenics CEO Discusses Q4 2010 Results - Earnings Call Transcript.

Antigenics Inc. is a biotechnology company founded in 1994 by Garo H. Armen and Pramod K. Srivastava. The company focuses on cancer vaccines, .

shares of antigenics investing information Antigenics+inc Roadpharmaceutical company current agenus inc page stock by into, develops treatments for best .

an·ti·gen ( n t -j n) also an·ti·gene (-j n ). n. A substance that when introduced into the body stimulates the production of an antibody. .

Sitemap